您的位置: 首页 > 农业专利 > 详情页

FORME CRISTALLINE II DE DAROLUTAMIDE
专利权人:
SANDOZ AG
发明人:
ADAMER, VERENA,MARTIN, NOLWENN,THALER, ANDREA,WERNER, VERONIKA,RANEBURGER, JOHANNES,SCHWARZ, FRANZ XAVER,LEGEN, IGOR,JEREB, REBEKA
申请号:
CA3092230
公开号:
CA3092230A1
申请日:
2019.02.25
申请国别(地区):
CA
年份:
2019
代理人:
摘要:
The present invention relates to a crystalline form of darolutamide and to a process for its preparation. Furthermore, the invention relates to a pharmaceutical composition comprising said crystalline form of darolutamide, preferably in a predetermined and/or effective amount, and at least one pharmaceutically acceptable excipient. The present invention also relates to 5 pharmaceutical compositions comprising darolutamide at a high drug load. The pharmaceutical composition of the present invention can be used as a medicament, in particular for the treatment of prostate cancer.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充